V-Square Quantitative Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.56M Sell
28,176
-1,259
-4% -$166K 0.34% 39
2026
Q1
$4.1M Buy
29,435
+1,155
+4% +$162K 0.43% 27
2025
Q4
$3.47M Sell
28,280
-2,771
-9% -$337K 0.36% 34
2025
Q3
$3.45M Buy
31,051
+1,492
+5% +$170K 0.58% 31
2025
Q2
$3.28M Buy
29,559
+560
+2% +$59.6K 0.44% 34
2025
Q1
$3.25M Buy
28,999
+203
+0.7% +$20.9K 0.47% 33
2024
Q4
$2.66M Buy
28,796
+1,622
+6% +$146K 0.38% 42
2024
Q3
$2.28M Buy
27,174
+446
+2% +$34K 0.33% 49
2024
Q2
$1.83M Buy
26,728
+891
+3% +$59.5K 0.3% 52
2024
Q1
$1.89M Buy
25,837
+5,072
+24% +$390K 0.26% 54
2023
Q4
$1.68M Buy
20,765
+9,986
+93% +$777K 0.3% 43
2023
Q3
$808K Buy
10,779
+3,076
+40% +$237K 0.36% 51
2023
Q2
$594K Sell
7,703
-95
-1% -$7.58K 0.43% 48
2023
Q1
$647K Buy
+7,798
New +$646K 0.6% 41

Other funds holding GILD

V-Square Quantitative Management's GILD Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Gilead Sciences (GILD) stake by 4.3% in Q2 2026, selling an estimated $166K and leaving 28,176 shares worth $3.56M. The position accounts for 0.34% of the portfolio, ranked #39.

V-Square Quantitative Management first reported a position in GILD in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.1M in Q1 2026. 931 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • V-Square Quantitative Management held 28,176 shares of Gilead Sciences worth $3.56M as of Q2 2026.
  • V-Square Quantitative Management sold 1,259 Gilead Sciences shares in Q2 2026, an estimated $166K.
  • Gilead Sciences made up 0.34% of V-Square Quantitative Management's portfolio in Q2 2026, its #39 holding.
  • V-Square Quantitative Management first reported a position in Gilead Sciences in Q1 2023 and has held it in 14 quarters since.
  • V-Square Quantitative Management's Gilead Sciences position peaked at $4.1M in Q1 2026.
  • 931 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.